Abstract
The effect of pyrimethamine and the combination of pyrimethamine-sulfadoxine (Fansidar) upon the termination of the acute attack of vivax malaria was studied in Thailand. Pyrimethamine was found to be ineffective, providing clearance of parasitaemia in only two of six patients by the end of seven days following treatment. The combination, administered in a two-tablet single dose (sulfadoxine 1 gm, pyrimethamine 50 mg) eliminated parasitaemia in only six of ten patients within seven days. Three tablets (sulfadoxine 1 . 5 gm, pyrimethamine 75 mg) given to 11 patients, provided clearance of parasitaemia in all within seven days; however, mean parasite and fever clearance times in this group were prolonged at 90 and 50 hours respectively. Chloroquine remains the drug of choice for the termination of the acute attack of vivax malaria. Subsequent primaquine is necessary for the prevention of relapse.
References
Jan 1, 1976·The American Journal of Tropical Medicine and Hygiene·E B DoberstynP Sonkon
Jan 1, 1975·Transactions of the Royal Society of Tropical Medicine and Hygiene·H E SegalB F Castaneda
Feb 1, 1973·Experimental Parasitology·V C McCarthy, D F Clyde
May 1, 1973·The American Journal of Tropical Medicine and Hygiene·W ChinS Kosakal
Citations
Jan 9, 1993·Lancet·G S MurphyS Harjosuwarno
Jan 9, 1998·Infectious Disease Clinics of North America·L M Barat, P B Bloland
Jul 15, 1982·The New England Journal of Medicine·I K Schwartz, C C Campbell
Apr 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph M Vinetz
Jun 23, 2010·Antimicrobial Agents and Chemotherapy·Alyson M AuliffQin Cheng
May 25, 2004·Antimicrobial Agents and Chemotherapy·Michael KorsinczkyQin Cheng
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Michele D HastingsCarol Hopkins Sibley
Jul 14, 2012·PloS One·Alyson M AuliffJohn H Adams
Dec 2, 2010·The American Journal of Tropical Medicine and Hygiene·Miao MiaoLiwang Cui
Jan 18, 2007·Annals of Tropical Medicine and Parasitology·K H Rieckmann
Dec 5, 1987·Lancet·A M OduolaR E Desjardins
Jan 1, 1994·Fundamental & Clinical Pharmacology·J Karbwang, K Na-Bangchang
Oct 1, 1992·European Journal of Drug Metabolism and Pharmacokinetics·V SinghasivanonI Djaja Lika
Nov 1, 1991·British Journal of Clinical Pharmacology·K Na BangchangD J Back
Sep 20, 2007·Expert Opinion on Drug Safety·Rana ChattopadhyaySanjai Kumar
Aug 11, 2004·Acta Tropica·Philippe Eldin de PécoulasLeonardo K Basco
Oct 25, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Mandana AfsharpadNavid D Djadid
Sep 27, 2005·Molecular and Biochemical Parasitology·Sonia Y HuntCarol Hopkins Sibley
Oct 20, 2010·Antimicrobial Agents and Chemotherapy·Md Tauqeer AlamVenkatachalam Udhayakumar
Feb 14, 2006·The Journal of General and Applied Microbiology·Meenaksui P SapreMandakini B Patil
Nov 18, 2005·The American Journal of Tropical Medicine and Hygiene·Myriam Arévalo-HerreraSócrates Herrera
Nov 18, 2005·The American Journal of Tropical Medicine and Hygiene·Myriam Arévalo-HerreraSócrates Herrera
Aug 1, 1983·Revista de saúde pública·J J Ferraroni